Celerion is the premier provider of innovative early stage clinical research solutions with facilities strategically located around the world in North America, Europe, and Asia. With over 40 years of experience, advanced scientific and technological expertise is applied to clinical research (over 750 beds in Phase I and II clinical Proof-of-Concept, cardiac safety services, NDA-enabling clinical pharmacology, ADME), clinical pharmacology sciences (modeling/simulation, study design, medical writing, biostatistics, PK/PD), small and large molecule bioanalytical services (preclinical through late stage), and drug development services. Key therapeutic areas include metabolic diseases, respiratory, inflammation, cardiovascular, hypertension, oncology, and infectious diseases.